Psychostimulant Effect of the Synthetic Cannabinoid JWH-018 and AKB48: Behavioral, Neurochemical, and Dopamine Transporter Scan Imaging Studies in Mice
暂无分享,去创建一个
M. A. De Luca | L. Ferraro | S. Beggiato | K. Varani | F. Vincenzi | P. Borea | M. D. De Luca | G. Di Domenico | F. De-Giorgio | M. Pasquali | A. Boschi | L. Uccelli | G. Serpelloni | M. Marti | G. Pupillo | S. Bilel | C. Rimondo | A. Ossato | I. Canazza
[1] N. Volkow,et al. Neurocircuitry of Addiction , 2010, Neuropsychopharmacology.
[2] D. Lovinger,et al. Endocannabinoid modulation of dopamine neurotransmission , 2017, Neuropharmacology.
[3] P. Kalivas,et al. New vistas on cannabis use disorder , 2017, Neuropharmacology.
[4] J. Kahn,et al. Acute effects of synthetic cannabinoids: Update 2015 , 2017, Substance abuse.
[5] P. Pinton,et al. Pharmaco‐toxicological effects of the novel third‐generation fluorinate synthetic cannabinoids, 5F‐ADBINACA, AB‐FUBINACA, and STS‐135 in mice. In vitro and in vivo studies , 2017, Human psychopharmacology.
[6] C. White,et al. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids , 2017, Journal of clinical pharmacology.
[7] C. Trapella,et al. Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence , 2016, Neuropharmacology.
[8] J. Kornhuber,et al. The behavioral profile of spice and synthetic cannabinoids in humans , 2016, Brain Research Bulletin.
[9] M. A. De Luca,et al. Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies , 2016, Psychopharmacology.
[10] K. Varani,et al. Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice , 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[11] M. A. De Luca,et al. Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135 , 2016, Neuropharmacology.
[12] M. A. De Luca,et al. Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants , 2016, Front. Neurosci..
[13] Z. Cooper. Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal , 2016, Current Psychiatry Reports.
[14] L. Fattore. Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis , 2016, Biological Psychiatry.
[15] R. Maldonado,et al. Involvement of the orexin/hypocretin system in the pharmacological effects induced by Δ9‐tetrahydrocannabinol , 2016, British journal of pharmacology.
[16] A. Ennaceur,et al. Preclinical animal anxiety research – flaws and prejudices , 2016, Pharmacology research & perspectives.
[17] L. Parsons,et al. Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid , 2015, Neuropharmacology.
[18] C. Trapella,et al. JWH-018 impairs sensorimotor functions in mice , 2015, Neuroscience.
[19] K. Varani,et al. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice , 2015, Neuropharmacology.
[20] M. H. Cheng,et al. Insights into the Modulation of Dopamine Transporter Function by Amphetamine, Orphenadrine, and Cocaine Binding , 2015, Front. Neurol..
[21] Renée Kinden,et al. Cannabinoids & Stress: Impact of HU-210 on behavioral tests of anxiety in acutely stressed mice , 2015, Behavioural Brain Research.
[22] Abraham Weizman,et al. Alterations in brain neurotrophic and glial factors following early age chronic methylphenidate and cocaine administration , 2015, Behavioural Brain Research.
[23] Matt Anderson,et al. European Monitoring Centre for Drugs and Drug Addiction , 2014 .
[24] M. Pistis,et al. Enhanced Endocannabinoid-Mediated Modulation of Rostromedial Tegmental Nucleus Drive onto Dopamine Neurons in Sardinian Alcohol-Preferring Rats , 2014, The Journal of Neuroscience.
[25] A. Duatti,et al. Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P. , 2014, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[26] G. Laviola,et al. A behavioural test battery to investigate tic-like symptoms, stereotypies, attentional capabilities, and spontaneous locomotion in different mouse strains , 2014, Behavioural Brain Research.
[27] Tracy L. Brewer,et al. A review of clinical manifestations in adolescent and young adults after use of synthetic cannabinoids. , 2014, Journal for specialists in pediatric nursing : JSPN.
[28] G. Panagis,et al. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity. , 2013, The international journal of neuropsychopharmacology.
[29] Tony J. Prescott,et al. Whisker Movements Reveal Spatial Attention: A Unified Computational Model of Active Sensing Control in the Rat , 2013, PLoS Comput. Biol..
[30] John Q. Wang,et al. Differential regulation of locomotor activity to acute and chronic cocaine administration by acid-sensing ion channel 1a and 2 in adult mice , 2013, Neuroscience.
[31] M. Barratt,et al. Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. , 2013, Drug and alcohol dependence.
[32] V. Auwärter,et al. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. , 2013, Addiction.
[33] V. Setola,et al. Neurochemical profiles of some novel psychoactive substances. , 2013, European journal of pharmacology.
[34] G. Laviola,et al. Behavioral Responses to Acute and Sub-chronic Administration of the Synthetic Cannabinoid JWH-018 in Adult Mice Prenatally Exposed to Corticosterone , 2013, Neurotoxicity Research.
[35] B. Lutz,et al. Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission , 2012, Neuropsychopharmacology.
[36] V. Pickel,et al. Cannabinoid modulation of the dopaminergic circuitry: Implications for limbic and striatal output , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[37] J. Rhodes,et al. Acute locomotor responses to cocaine in adolescents vs. adults from four divergent inbred mouse strains , 2010, Genes, brain, and behavior.
[38] K. Fuxe,et al. Nanomolar concentrations of cocaine enhance D2-like agonist-induced inhibition of the K+-evoked [3H]-dopamine efflux from rat striatal synaptosomes: a novel action of cocaine , 2010, Journal of Neural Transmission.
[39] J. Javitch,et al. Syntaxin 1A Interaction with the Dopamine Transporter Promotes Amphetamine-Induced Dopamine Efflux , 2008, Molecular Pharmacology.
[40] A. Duatti,et al. Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC , 2008, Journal of Nuclear Medicine.
[41] A. Duatti,et al. Novel Tc-99m radiotracers for brain imaging , 2007 .
[42] W. A. Owens,et al. CB1‐independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum , 2007, Journal of neurochemistry.
[43] Natalia Auricchio,et al. CT with a CMOS flat panel detector integrated on the YAP-(S)PET scanner for in vivo small animal imaging , 2007 .
[44] P. Hof,et al. A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy , 2005, Neuroscience.
[45] E Sylvester Vizi,et al. Involvement of Cannabinoid Receptors in the Regulation of Neurotransmitter Release in the Rodent Striatum: A Combined Immunochemical and Pharmacological Analysis , 2005, The Journal of Neuroscience.
[46] M. Koch,et al. Effects of the cannabinoid receptor agonist win 55,212-2 on operant behavior and locomotor activity in rats , 2005, Pharmacology Biochemistry and Behavior.
[47] Daniele Lecca,et al. Dopamine and drug addiction: the nucleus accumbens shell connection , 2004, Neuropharmacology.
[48] A. Del Guerra,et al. Performance evaluation of the fully engineered YAP-(S)PET scanner for small animal imaging , 2004, IEEE Transactions on Nuclear Science.
[49] P. Broderick,et al. Acute and subacute effects of risperidone and cocaine on accumbens dopamine and serotonin release using in vivo microvoltammetry on line with open-field behavior , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[50] Sanjiv Sam Gambhir,et al. AMIDE: a free software tool for multimodality medical image analysis. , 2003, Molecular imaging.
[51] R. Moratalla,et al. Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia , 2003, Neuroscience.
[52] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[53] B. Szabo,et al. Effects of Cannabinoids on Dopamine Release in the Corpus Striatum and the Nucleus Accumbens In Vitro , 1999, Journal of neurochemistry.
[54] J. Walker,et al. Motor actions of cannabinoids in the basal ganglia output nuclei. , 1999, Life sciences.
[55] M. Christie,et al. The Anxiogenic-Like and Anxiolytic-Like Effects of MDMA on Mice in the Elevated Plus-Maze A Comparison With Amphetamine , 1999, Pharmacology Biochemistry and Behavior.
[56] C. Breivogel,et al. The Functional Neuroanatomy of Brain Cannabinoid Receptors , 1998, Neurobiology of Disease.
[57] F. Fonseca,et al. Role of the Endogenous Cannabinoid System in the Regulation of Motor Activity , 1998, Neurobiology of Disease.
[58] R. Mechoulam,et al. Biphasic Effects of Anandamide , 1998, Pharmacology Biochemistry and Behavior.
[59] M. Brecht,et al. Functional architecture of the mystacial vibrissae , 1997, Behavioural Brain Research.
[60] G. Laviola,et al. d-amphetamine conditioned place preference in developing mice: relations with changes in activity and stereotypies. , 1994, Behavioral neuroscience.
[61] J. Costentin,et al. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions , 1994, Behavioural Brain Research.
[62] P. Broderick. In vivo electrochemical studies of gradient effects of (SC) cocaine on dopamine and serotonin release in dorsal striatum of conscious rats , 1993, Pharmacology Biochemistry and Behavior.
[63] R. Wechsler,et al. Real time detection of acute (IP) cocaine-enhanced dopamine and serotonin release in ventrolateral nucleus accumbens of the behaving Norway rat , 1993, Pharmacology Biochemistry and Behavior.
[64] A. Gorman,et al. Anxiogenic effects of acute and chronic cocaine administration: Neurochemical and behavioral studies , 1992, Pharmacology Biochemistry and Behavior.
[65] P. Broderick. Cocaine: On-line analysis of an accumbens amine neural basis for psychomotor behavior , 1991, Pharmacology Biochemistry and Behavior.
[66] M. Giordano,et al. The effects of cocaine on multivariate locomotor behavior and defecation , 1990, Behavioural Brain Research.
[67] R. Roth,et al. Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis , 1989, Neuroscience Letters.
[68] U. Ungerstedt,et al. Ca2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission. , 1989, European journal of pharmacology.
[69] D. Treit,et al. Thigmotaxis as a test for anxiolytic activity in rats , 1988, Pharmacology Biochemistry and Behavior.
[70] J. B. Justice,et al. Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine. , 1987, European journal of pharmacology.
[71] P. Sanberg,et al. The topography of amphetamine and scopolamine-induced hyperactivity: toward an activity print. , 1987, Behavioral neuroscience.
[72] R. Wise,et al. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. , 1977, Canadian journal of psychology.
[73] R N Walsh,et al. The Open-Field Test: a critical review. , 1976, Psychological bulletin.
[74] S. Snyder,et al. Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes. , 1975, The Journal of pharmacology and experimental therapeutics.
[75] J. Howes,et al. The effect of Δ9-tetrahydrocannabinol on the uptake and release of 14C-dopamine from crude striatal synaptosomal preparations , 1974 .
[76] K. Sharma,et al. Showcase: Latest dental equipment , 2005, British Dental Journal.
[77] P. Mariani,et al. Biodistribution of nanostructured lipid carriers: a tomographic study. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[78] B. Logan,et al. Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs. , 2014, Forensic science review.
[79] K. Scherer,et al. Trends and developments Courants et tendances , 2008 .
[80] Allan MacKenzie-Graham,et al. Brain atlases and neuroanatomic imaging. , 2007, Methods in molecular biology.
[81] J. Avery. Critical review. , 2006, The Journal of the Arkansas Medical Society.
[82] V. Cestari,et al. D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse , 2005, Psychopharmacology.
[83] J. Hallera,et al. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents , 2004 .
[84] S. Kish,et al. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. , 1994, Molecular pharmacology.
[85] M. Kuhar,et al. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. , 1990, Life sciences.
[86] P. Kalivas,et al. Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens , 1990, Synapse.
[87] M. Geyer,et al. Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs. , 1989, NIDA research monograph.
[88] N. Weiner,et al. Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes. , 1987, The Journal of pharmacology and experimental therapeutics.
[89] J. Howes,et al. The effect of delta9-tetrahydrocannabinol on the uptake and release of 14C-dopamine from crude striatal synaptosoma; preparations. , 1974, Neuropharmacology.